GASTROINTESTINAL ADENOCARCINOMA
Clinical trials for GASTROINTESTINAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stomach cancer: experimental drug BHB810 enters human trials
Disease control Recruiting nowThis study tests a new drug, BHB810, in adults with advanced stomach or gastroesophageal junction cancer that has not responded to standard treatments. The drug is given as an IV infusion every two weeks. The main goals are to check safety and find the best dose, while also seein…
Matched conditions: GASTROINTESTINAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: BigHat Biosciences, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New radiation method may boost immune attack on tumors
Symptom relief Recruiting nowThis study compares a new radiation technique called lattice radiation therapy (LRT) to standard stereotactic body radiation therapy (SBRT) for people with solid tumors that have spread to soft tissues. The goal is to see if LRT shrinks tumors better and helps the immune system f…
Matched conditions: GASTROINTESTINAL ADENOCARCINOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC